Peptides From Fentanyl Precursor Suppliers and Two Reported Retatrutide Deaths: What Florida Sellers and Clinicians Face Now

Two stories published a week apart this month should change how anyone in the peptide business thinks about risk. On October 6, The Wall Street Journal reported that Chinese chemical companies that have supplied fentanyl ingredients to drug cartels are now selling peptides to Americans. On October 13, CBS News reported that FDA has received two death reports tied to bootleg retatrutide, the unapproved Eli Lilly weight-loss compound sold online as "Reta."

Put those together and a research use only peptide case stops looking like a labeling dispute. It looks like an overseas drug supply chain with deaths attached, and federal agents investigate those very differently. If you sell, reship, inject or recommend RUO peptides in Florida, here is what the reporting shows and where the criminal exposure sits.

A research use only peptide case can stop looking like a labeling dispute and start looking like an overseas drug supply chain.

Key Takeaways

• Fla. Stat. § 499.0051(9) makes a knowing sale of contraband prescription drugs that results in death a first-degree felony, punishable by up to life.
• Blockchain analysts say most China-based chemical vendors taking crypto list both peptides and fentanyl precursors, so peptide payments surface in drug trafficking investigations.
• Selling an unapproved new drug violates 21 U.S.C. § 331(d); with intent to defraud or mislead, 21 U.S.C. § 333(a)(2) makes it a federal felony.
• Reshippers who break down smuggled master cartons face 18 U.S.C. § 545 smuggling exposure, a 20-year felony that also serves as a money laundering predicate.
• The Southern and Middle Districts of Florida have already indicted China-based chemical companies, and Florida peptide sellers should expect those offices to follow the money.

What the Journal and CBS Found

The Journal relied on blockchain tracing firms that follow crypto payments to Chinese chemical sellers. TRM Labs published its data the same day. Of more than 150 China-based chemical manufacturers TRM has identified accepting cryptocurrency, about 75 percent list both fentanyl precursors and peptides, and TRM calls that a lower bound. Crypto payments to vendors selling both rose from $28.2 million in 2023 to $37.3 million in 2025, with U.S. buyers accounting for about 57 percent of the value TRM could place by country.

One vendor in TRM's data was charged by the Justice Department in 2023 with conspiring to manufacture and distribute fentanyl. As of September 2026, its website listed Melanotan II and semaglutide next to fentanyl-class chemicals.

About 75 percent of the China-based chemical manufacturers TRM has identified accepting cryptocurrency list both fentanyl precursors and peptides. TRM calls that a lower bound.

CBS obtained the two death records from FDA's Adverse Event Reporting System through a public records request. In July, a healthcare professional told FDA that a 41-year-old woman went into cardiac arrest after taking retatrutide from "an unreliable source." In September, FDA learned that a 49-year-old patient had died after severe dehydration, malnutrition and cardiac arrest; a licensed nurse had allegedly sent her a link to an online peptide vendor, sold her vials and recommended doses. CBS could not verify either account, and neither record establishes that the product caused a death.

What Investigators Are Building From This

Most criminal peptide cases so far began with an FDA warning letter and ended in a plea to misbranding or unapproved drug counts. What pushed them from letter to indictment was consistent: selling after a warning, false purity and origin claims, forged certificates of analysis, dosing advice, customs deception and injured customers. In July, a federal judge in the Northern District of Indiana sentenced one RUO peptide vendor to 70 months after hearing about the harm his products caused.

This month's reporting adds two things those cases rarely had at the start. The first is harm. A death record naming a product and a seller moves a file up the queue, and an FDA OCI investigation into a death will look at everyone between the factory and the patient. The second is the China connection. Once payments run to vendors that also sell fentanyl precursors, Homeland Security Investigations, DEA, IRS Criminal Investigation and Treasury all have reasons to look, and analytics firms already map those wallets.

Shipping is being worked too. Customs officers in Cincinnati broke up a master carton scheme this spring in which a China-based shipper hid individual orders of GLP-1 peptides, including retatrutide, semaglutide and tirzepatide, inside larger boxes. According to the Journal, CBP recorded more than 2,400 seizures covering over 130,000 vials between October 2025 and late August 2026. Those orders carried U.S. addresses.

CBP recorded more than 2,400 seizures covering over 130,000 vials between October 2025 and late August 2026, according to the Journal. Those orders carried U.S. addresses.

Florida is not on the edge of this. In October 2023, the Justice Department announced eight indictments of China-based chemical companies, three in the Southern District of Florida and five in the Middle District of Florida. Those offices know how these vendors ship and get paid. And two of the five FDA warning letters dated August 24, 2026 went to Florida companies, one on each coast. Both name retatrutide.

The Charges: Florida Law First, Then Federal

Florida's Drug and Cosmetic Act reaches this conduct without FDA. Under Fla. Stat. § 499.003(11), a "contraband prescription drug" includes any adulterated drug and any prescription drug that arrives without a transaction history, transaction information or transaction statement. A vial whose strength or purity falls short of its label is adulterated under § 499.006(7), and Lilly says it keeps finding bootleg retatrutide with the wrong dose and with contaminants. An overseas vial with no transaction records fits the other category.

Section 499.0051 stacks the penalties. Knowingly selling contraband prescription drugs is a second-degree felony, punishable by up to 15 years. At $25,000 in aggregated value, it is a first-degree felony with mandatory fines. Great bodily harm also makes it first-degree. If the conduct results in death, subsection (9) makes it a first-degree felony punishable by up to life. A state prosecutor does not need FDA's permission to file that charge.

"If the conduct results in death, subsection (9) makes it a first-degree felony punishable by up to life. A state prosecutor does not need FDA's permission to file that charge."— Aaron M. Cohen, Principal Attorney

The federal counts start with the Food, Drug, and Cosmetic Act. Introducing an unapproved new drug into interstate commerce violates 21 U.S.C. § 331(d) and § 355(a). Under 21 U.S.C. § 333(a), that is a strict liability misdemeanor, or a three-year felony when done with intent to defraud or mislead. In recent RUO cases, prosecutors have pleaded the research use disclaimer itself as the deception aimed at FDA.

That reaches reshippers who break down master cartons and organizers who split bulk orders.

The Money and the Sentence

The money creates its own counts. Sending payments abroad to promote smuggling is international money laundering under 18 U.S.C. § 1956(a)(2)(A), another 20-year felony, and wire fraud and conspiracy under 18 U.S.C. § 1343 and § 371 often ride along. Some vendors are also sanctioned. In September 2025, Treasury designated a China-based chemical company for synthetic opioid trafficking whose catalog, according to TRM, also listed peptides. A willful payment to a sanctioned party is a crime under 50 U.S.C. § 1705.

At sentencing, the FDCA guideline, U.S.S.G. § 2N2.1, sends fraud cases to the § 2B1.1 loss table, where sales volume drives the range. A death the judge connects to the product will weigh heavily under 18 U.S.C. § 3553(a), charged or not.

Early Mistakes That Turn a Warning Letter Into an Indictment

The same errors show up in most peptide files that go criminal.

• Relying on the label. FDA judges intended use from the whole website under 21 C.F.R. § 201.128. The August letters treated bacteriostatic water, dosing calculators and peptide guides as proof of human use.
• Cleaning house after the news. Deleting product pages, chats, order histories or supplier messages once an investigation is foreseeable can be charged as obstruction under 18 U.S.C. § 1519, a 20-year felony. Preserve everything.
• Talking to agents to clear it up. Anything you tell FDA-OCI or HSI about sources and customers becomes their roadmap. Be polite, take a card and call a lawyer.
• Selling through the warning. Continuing after a warning letter or a customs detention notice is the fact that has repeatedly moved peptide files from regulators to prosecutors.
• Clinicians recommending RUO products. A nurse or physician who sends patients to an RUO website with a dosing schedule is part of the distribution chain in the government's view, and a licensing board will see it the same way.

Consider a Palm Beach County nurse practitioner who sells nothing. She tells weight-loss patients where to buy reta online and texts them a dosing chart. One patient is hospitalized. The website receives a federal grand jury subpoena, and her referral code appears in its records next to that patient's orders. She now has federal questions about her role in the distribution and a licensing inquiry, before anyone has asked for her side.

How We Defend These Cases Before Charges

Federal investigation defense in a peptide case starts with learning who is investigating and why. FDA-OCI, HSI, DEA and Florida's Department of Business and Professional Regulation ask different questions, and the answer tells us whether the case is about labeling, smuggling, money or a death.

Then we lock down the record: a preservation hold, quarantined inventory, and independent testing of retained product through counsel so the results stay privileged. Purity and identity decide whether the state can call the product adulterated and whether an injury can be tied to it. We also rebuild the supply chain, including what the client knew about the vendor, because knowledge of a supplier's precursor business is a fact question we want answered before an agent asks it.

With that record, a white collar defense attorney can make an informed choice between litigation and cooperation. Prosecutors building the China side want the supplier, the payment trail and the reshipper, and a proffer session negotiated on the right terms can change the charge or the sentence. That decision comes after we know the exposure, not before.

Why the Next Few Months Matter

The pressure on FDA is now public. Lilly says it has reported more than 14,000 online listings to authorities and has filed civil suits against sellers in August and again in October, and poison center exposures more than tripled between the first and third quarters. Agencies answer that kind of record with cases.

The general federal limitations period is five years under 18 U.S.C. § 3282, so sales going back to late 2021 remain chargeable. Subpoenas to payment processors, crypto exchanges and shippers go out quietly and come back with customer lists. Most people learn they are under federal investigation when a target letter arrives or agents knock. The time to act is while the charging decision is still open.

Common Questions

Under Investigation Over Peptides in Florida?

If you sell, reship, prescribe or recommend peptides and you have received an FDA warning letter, a customs notice, a grand jury subpoena or a call from an agent, get advice before you make a statement or change your website. AMC Defense Law represents people and companies in federal and Florida investigations involving peptides, compounded drugs and FDA enforcement, from our Boca Raton office and nationwide.

AMC Defense Law represents people and companies in federal and Florida investigations involving peptides, compounded drugs and FDA enforcement, from Boca Raton and nationwide.

Consultations are confidential. Call 561-542-5494 or email amc@amcdefenselaw.com.

If you or your loved ones have been arrested or are under investigation over peptides, call Aaron M. Cohen, 24 hours a day to get help.

This article is general information, not legal advice, and reading it does not create an attorney-client relationship. Facts are drawn from published news reporting and public government records. Adverse event records are unverified, charges are allegations, and every person is presumed innocent unless and until proven guilty. Prior results do not guarantee a similar outcome.